Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial

Treatment with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) or escalated(e)-BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisolone) remains the international standard of care for advanced-stage classical Hodgkin lymphoma (HL). We perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, James, Collins, Angela, Fowler, Alexis, Karanth, Mamatha, Saha, Chandan, Docherty, Suzanne, Padayatty, Joseph, Maw, Kyaw, Lentell, Isabel, Cooke, Lisa, Hodson, Andrew, Shah, Nimish, Sadullah, Shalal, Grigoropoulos, Nicholas, Qian, Wendi, Kirkwood, Amy A., Uttenthal, Benjamin J., Johnson, Peter, Follows, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960595/
https://www.ncbi.nlm.nih.gov/pubmed/33641019
http://dx.doi.org/10.1007/s00277-021-04460-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960595/
https://www.ncbi.nlm.nih.gov/pubmed/33641019
http://dx.doi.org/10.1007/s00277-021-04460-9

Ejemplares similares